Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
BörsenkürzelHNGE
Name des UnternehmensHinge Health Inc
IPO-datumMay 22, 2025
Gegründet am2016
CEOMr. Daniel (Dan) Perez
Anzahl der mitarbeiter1514
WertpapierartOrdinary Share
GeschäftsjahresendeMay 22
Addresse455 Market Street
StadtSAN FRANCISCO
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl94105
Telefon14156898429
Websitehttps://en-gb.hingehealth.com/
BörsenkürzelHNGE
IPO-datumMay 22, 2025
Gegründet am2016
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten